September #137 : The Elite Meet - by Laura Whitehorn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

Trouble in Paradise

The Shore Thing

Heads of the Class

Solo Shot

Got Milk Thistle?

The Elite Meet

We've Got Your Number

Flu Fight

Doctors Ordered

Priority Male

Condoms on the Side

Sexpert-September 2007

Trainer's Bench-September 2007

Get a Nightlife

Cheat Sheet

The Food Network

The Princess and the HIV

Our Space


Crowning Achievement

Hot Dates-September 2007

The Jury is Out

Holding Out for a Hero

28 Profiles in Courage

Blown Sideways

Star Billing

Editor's Letter-September 2007

Mailbox-September 2007

Catch of the Month-September 2007

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

September 2007

The Elite Meet

by Laura Whitehorn

Some positive people don’t need meds. Are their genetic mysteries about to crack HIV’s code?

Bruce Walker, MD, wants HIV-positive immune systems to exert a little self-control. “The immune system is able to contain other viruses,” says Walker, widely known for his groundbreaking work on the subject. He is investigating how it can do that for HIV.

The answer may lie within the genes of those positive people who manage HIV without taking meds—some for more than 25 years so far. These folks fall into two groups—either viremic (viral load consistently under 2,000 for at least one no-med year) or elite controllers (viral load consistently below 50 without meds). Walker and his team are looking for more members of both groups to fill out his HIV elite controllers study.

In June, Walker, director of Boston’s Partners AIDS Research Center, said, “We began genotyping the DNA of the first 600 controllers,” including 300 viremic and 300 elite, plus 900 progressors, or positive people who do need meds.

Comparing these genetic profiles may reveal, for example, why some people’s immune systems seek out certain HIV surface proteins. “For each person we will get 650,000 pieces of data,” Walker says. Initial results from the first round were expected in August. Paul de Bakker, PhD, statistical geneticist on the study, adds that the small pool (fewer than 1,000 people) “limits our statistical ability to find the [relevant] variants.” More participants (you could qualify if you’ve been off meds for at least a year now) would produce more significant results. Walker estimates that some 25% of all positive people may fit the trial criteria.

To join the study, you don’t have to travel—just your blood sample does. Your doc sends it off with a bit of your treatment history. Your participation may help unlock the secrets of HIV treatment—and potential vaccines. Call 617.726.5536; or e-mail

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.